Credit Suisse’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-162,061
| Closed | -$35.2M | – | 4757 |
|
|
2021
Q1 | $35.2M | Buy |
162,061
+141,997
| +708% | +$26.7M | 0.02% | 869 |
|
|
2020
Q4 | $2.32M | Buy |
20,064
+12,654
| +171% | +$1.42M | ﹤0.01% | 2708 |
|
|
2020
Q3 | $721K | Buy |
7,410
+3,407
| +85% | +$392K | ﹤0.01% | 3157 |
|
|
2020
Q2 | $491K | Sell |
4,003
-36,540
| -90% | -$4.15M | ﹤0.01% | 3344 |
|
|
2020
Q1 | $3.55M | Buy |
40,543
+34,623
| +585% | +$3.67M | ﹤0.01% | 1752 |
|
|
2019
Q4 | $619K | Sell |
5,920
-194,107
| -97% | -$21.8M | ﹤0.01% | 3438 |
|
|
2019
Q3 | $23M | Buy |
+200,027
| New | +$30.4M | 0.02% | 829 |
|
|
2018
Q4 | – | Sell |
-40,259
| Closed | -$6.95M | – | 4056 |
|
|
2018
Q3 | $6.95M | Buy |
40,259
+38,555
| +2,263% | +$5.56M | 0.01% | 1490 |
|
|
2018
Q2 | $239K | Sell |
1,704
-1,946
| -53% | -$276K | ﹤0.01% | 3708 |
|
|
2018
Q1 | $411K | Sell |
3,650
-4,427
| -55% | -$557K | ﹤0.01% | 3455 |
|
|
2017
Q4 | $1.07M | Sell |
8,077
-40,531
| -83% | -$4.76M | ﹤0.01% | 2937 |
|
|
2017
Q3 | $4.93M | Sell |
48,608
-5,800
| -11% | -$621K | ﹤0.01% | 1770 |
|
|
2017
Q2 | $5.46M | Sell |
54,408
-60,976
| -53% | -$6.56M | 0.01% | 1579 |
|
|
2017
Q1 | $14M | Sell |
115,384
-29,557
| -20% | -$3.63M | 0.01% | 1034 |
|
|
2016
Q4 | $16.2M | Buy |
144,941
+135,676
| +1,464% | +$16.3M | 0.02% | 920 |
|
|
2016
Q3 | $1.23M | Sell |
9,265
-7,721
| -45% | -$738K | ﹤0.01% | 2786 |
|
|
2016
Q2 | $1.56M | Buy |
16,986
+14,044
| +477% | +$1.18M | ﹤0.01% | 2539 |
|
|
2016
Q1 | $212K | Sell |
2,942
-16,301
| -85% | -$894K | ﹤0.01% | 3662 |
|
|
2015
Q4 | $1.34M | Buy |
19,243
+16,216
| +536% | +$1.32M | ﹤0.01% | 2586 |
|
|
2015
Q3 | $277K | Sell |
3,027
-8,111
| -73% | -$902K | ﹤0.01% | 3769 |
|
|
2015
Q2 | $1.37M | Sell |
11,138
-10,468
| -48% | -$1.19M | ﹤0.01% | 2889 |
|
|
2015
Q1 | $1.97M | Sell |
21,606
-6,766
| -24% | -$549K | ﹤0.01% | 2405 |
|
|
2014
Q4 | $1.92M | Buy |
28,372
+22,696
| +400% | +$1.66M | ﹤0.01% | 2571 |
|
|
2014
Q3 | $459K | Buy |
5,676
+2,015
| +55% | +$178K | ﹤0.01% | 3700 |
|
|
2014
Q2 | $393K | Sell |
3,661
-15,140
| -81% | -$1.05M | ﹤0.01% | 3967 |
|
|
2014
Q1 | $1.12M | Buy |
+18,801
| New | +$1.12M | ﹤0.01% | 3025 |
|
Other funds holding GWPH
Credit Suisse's GWPH Position: Q2 2021 in Review
Credit Suisse sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 162,061 shares — an estimated $35.2M sold.
Credit Suisse first reported a position in GWPH in Q1 2014 and held it in 26 quarters. The position peaked at $35.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Credit Suisse reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Credit Suisse sold 162,061 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $35.2M.
- Credit Suisse first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 26 quarters.
- Credit Suisse's GW Pharmaceuticals Plc American Depositary Shares position peaked at $35.2M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.